Bert from Finland

Registered at the short selling broker Skilling, 4 minutes ago.

» Try Skilling you too
69% of retail CFD accounts lose money.
Don't show again

Galera Therapeutics, Inc. (GRTX) shares information

Galera Therapeutics, Inc.


24h Change

2.98 %

GRTX

Live rate:

Stock data per Thursday 22 Oct, 2020

GRTX
NASDAQ
11.43
11.77
0.34 (+ 2.98%)
US Market is open

Live Stock price in graph for Galera Therapeutics, Inc. (GRTX)

Data updated continously for GRTX, showing up to the 500 most recent 100 data points

  • Latest Volume

    3,769 (-91.92 %)

  • Volume prev. day

    46,622

  • Avg. daily volume

    80,610

  • Market cap

    292,862,317

  • P/E ratio

    -4.16

  • Today high

    12.38

  • Today low

    11.52

  • 52 week high

    19.5

  • 52 week low

    5.58

  • YTD Change

    n/a

Quick links

Price target by analysts

The 4 latest analyst estimates, per Sunday 11 October, 2020, show the following high, low and average price targets.
Target Average: 17.75 USD
Target High: 30 USD
Target Low: 8 USD

 

Latest news about Galera Therapeutics, Inc.

Below you can find the most recent news posts about Galera Therapeutics, Inc., primarily from US and UK based news sources.

Galera Therapeutics Announces Dosing of First Patient in the Phase 1/2 GRECO-1 Clinical Trial of GC4711 in Combination with SBRT for Non-Small Cell Lung Cancer

Thursday, 22 October 2020, 14:00:00
Trial Supported in Part by NIH SBIR Grant
— GlobeNewswire


Insider Selling: Galera Therapeutics (NASDAQ:GRTX) Major Shareholder Sells 450,000 Shares of Stock

Thursday, 22 October 2020, 06:22:41
Galera Therapeutics (NASDAQ:GRTX) major shareholder Holdings A/S Novo sold 450,000 shares of the firm’s stock in a transaction dated Thursday, October 15th. The stock was sold at an average price of $11.00, for a total transaction of $4,950,000.00. Following the sale, the insider now owns 2,959,021 shares of the company’s stock, valued at $32,549,231. The […]
— Dispatch Tribunal


Galera Therapeutics (NASDAQ:GRTX) Major Shareholder Holdings A/S Novo Sells 450,000 Shares of Stock

Tuesday, 20 October 2020, 03:10:46
Galera Therapeutics (NASDAQ:GRTX) major shareholder Holdings A/S Novo sold 450,000 shares of the firm’s stock in a transaction on Thursday, October 15th. The stock was sold at an average price of $11.00, for a total transaction of $4,950,000.00. Following the completion of the sale, the insider now owns 2,959,021 shares in the company, valued at […]
— Daily Political


Galera completes enrollment in mid-stage study of lead drug in pancreatic cancer (NASDAQ:GRTX)

Tuesday, 14 July 2020, 00:06:02
Galera Therapeutics (NASDAQ:GRTX) has completed patient enrollment in its Phase 1b/2a trial of avasopasem manganese (GC4419) in combination with stereotact
— Seeking Alpha


The Daily Biotech Pulse: Pfizer’s Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic’s COVID-19 Connection

Thursday, 19 March 2020, 12:37:15
Here’s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) Biomerica, Inc. (NASDAQ: BMRA )( announced commencement of international shipment of rapid COVID-19 test) BioNTech SE – ADR (NASDAQ: BNTX ) Imara Inc (NASDAQ: IMRA ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 18) 89bio Inc (NASDAQ: ETNB ) AC Immune SA (NASDAQ: ACIU ) Acasti Pharma Inc (NASDAQ: ACST ) Accelerate Diagnostics Inc (NASDAQ: AXDX ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adamis Pharmaceuticals Corp (NASDAQ: ADM ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) ADMA Biologics Inc (NASDAQ: ADMA ) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) AEterna Zentaris Inc. (NASDAQ: AEZS ) Agenus Inc (NASDAQ: AGEN ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Aikido Pharma Inc (NASDAQ: AIKI ) Akorn, Inc. (NASDAQ: AKRX ) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AMAG Pharmaceuticals, Inc.
— Benzinga


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €/$ 20
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have GRTX available or trade one of the many other CFD stocks they have.
Risk warning: 75% of retail investor accounts lose money when trading CFDs with Capital.